Fusion Pharmaceuticals Is A Clinical Stage Biopharmaceutical Company Based In Hamiltonontariocanadawith Operations In Both The U Sand Canadathe Company Is Dedicated To Developing Next Generation Radiopharmaceuticals As Precision Medicines For Cancer Treatmentit Specializes In Targeted Alpha Therapeuticstatusing Its Proprietary Fast Cleara C Linker Technologywhich Connects Alpha Particle Emitting Isotopes To Antibodies And Other Targeting Molecules For Selective Tumor Therapy The Company S Product Pipeline Includes Fpi 1434Fpi 2059And Fpi 1966Aimed At Treating Various Cancers Such As Head And Neckbladdercolorectaland Gastric Cancersthese Products Can Be Utilized As Monotherapy Or In Combination Therapyfusion Pharmaceuticals Focuses On Expanding Its Pipeline Through In Licensing Targeting Molecules And Forming Strategic Partnershipsenhancing Its Ability To Improve Cancer Treatment Outcomes
